Metraipolis › archive › dc_f3ec4f100f90

TP53 and KRAS co-mutations are associated with worse outcomes in mucinous ovarian carcinomas — Europe PMC PMID:40896434

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40896434
DOI
10.3389/fonc.2025.1573801
License (as archived)
solo-consultazione
Archived
2026-11-10T15:00:33.499Z
SHA-256 of the archived text
6059fce88ba0b22bc607d7f5dcbbc1a711ff658891c4716bf78012cdfd0be153
Stable URL of this page
https://metraipolis.com/documento/dc_f3ec4f100f90

How to cite

TP53 and KRAS co-mutations are associated with worse outcomes in mucinous ovarian carcinomas — Europe PMC PMID:40896434 — Europe PMC (en), https://europepmc.org/article/MED/40896434 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f3ec4f100f90 (Metraipolis archive dc_f3ec4f100f90, sha256 6059fce88ba0b22bc607d7f5dcbbc1a711ff658891c4716bf78012cdfd0be153)
BibTeX
@misc{dcf3ec4f100f90,
  title = {TP53 and KRAS co-mutations are associated with worse outcomes in mucinous ovarian carcinomas — Europe PMC PMID:40896434},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40896434},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f3ec4f100f90; sha256 6059fce88ba0b22bc607d7f5dcbbc1a711ff658891c4716bf78012cdfd0be153},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40896434. Agents can read the archived copy with the MCP tool read_document.